Novo Integrated Sciences, Inc.
11120 NE 2nd Street, Suite 100
Bellevue, WA 98004
October 7, 2022
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Novo Integrated Sciences, Inc. | |
| Registration Statement on Form S-1 | ||
| CIK No. 0001138978 | ||
| File No. 333-267401 |
Ladies and Gentlemen:
In accordance with Rule 461 of the Securities Act of 1933, as amended, Novo Integrated Sciences, Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement be accelerated so that it will be declared effective at 5:00 p.m. Eastern Time on Wednesday, October 12, 2022, or as soon thereafter as possible.
* * * *
Very Truly Yours,
| Novo Integrated Sciences, Inc. | |
| /s/ Robert Mattacchione | |
| Robert Mattacchione | |
| Chief Executive Officer |
